Correlation between serum sclerostin level and bone density status in children on regular hemodialysis
Bone disease is frequently observed in chronic kidney disease (CKD) and increases a patient’s risk for fracture. Sclerostin is an osteocyte-derived negative regulator of bone formation. We aimed to assess serum sclerostin level as a bone marker in children with CKD on regular hemodialysis (HD) and d...
Main Authors: | Manal Abd Elsalam, Maha Zein El-Abden, Eman Mahmoud, Zakia Abo Zahab, Heba Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=5;spage=1022;epage=1031;aulast=Elsalam |
Similar Items
-
Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
by: Dina S Al-Zifzaf, et al.
Published: (2014-01-01) -
Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes
by: Maria Carolina Medeiros, et al.
Published: (2020-01-01) -
Serum sclerostin levels in rheumatoid arthritis and correlation with disease activity and bone mineral density
by: Urmila Dhakad, et al.
Published: (2019-01-01) -
Prevalence of low bone mineral density in ankylosing spondylitis, correlation with disease activity, and serum sclerostin levels
by: Anupam Wakhlu, et al.
Published: (2020-01-01) -
The correlation between sclerostin and bone mineral density in renal transplant recipients
by: Melahat Coban, et al.
Published: (2020-09-01)